Archives | LinksMedicus Free Medical News & Perspectives

Meta-analysis of randomized trials | Efficacy and safety of transcutaneous electrical nerve stimulation (TENS) for acute and chronic pain in adults.

22 Feb, 2022 | 08:32h | UTC

Efficacy and safety of transcutaneous electrical nerve stimulation (TENS) for acute and chronic pain in adults: a systematic review and meta-analysis of 381 studies (the meta-TENS study) – BMJ Open

M-A: Diagnostic features, management and prognosis of type 2 myocardial infarction compared to type 1 myocardial infarction.

22 Feb, 2022 | 08:34h | UTC

Diagnostic features, management and prognosis of type 2 myocardial infarction compared to type 1 myocardial infarction: a systematic review and meta-analysis – BMJ Open

Perspective | How to banish manels and manferences from scientific meetings.

22 Feb, 2022 | 08:23h | UTC

How to banish manels and manferences from scientific meetings – Nature

Early and late-onset syncope: insight into mechanisms.

22 Feb, 2022 | 08:29h | UTC

Early and late-onset syncope: insight into mechanisms – European Heart Journal

Commentary on Twitter

Early and late-onset syncope: insight into mechanisms https://t.co/OlAT50jIt8 @escardio #EHJ #ESCYoung #cardiotwitter @ehj_ed @rladeiraslopes pic.twitter.com/F2gzBH9X2i

— European Society of Cardiology Journals (@ESC_Journals) February 17, 2022

Review: Acute ischemic stroke and its challenges for the intensivist.

22 Feb, 2022 | 08:27h | UTC

Acute ischaemic stroke and its challenges for the intensivist – European Heart Journal. Acute Cardiovascular Care

Study suggests banning the promotion of soft drinks could be more effective than a sugar tax.

22 Feb, 2022 | 08:25h | UTC

Banning the promotion of soft drinks could be more effective than a sugar tax – The Conversation

Original Study: Industry levy versus banning promotion on soft drinks in Scotland: A distributional analysis – Food Policy

Association of a sweetened beverage tax with reduction in soda consumption in high school students.

Changes in food purchases after the Chilean policies on food labelling, marketing, and sales in schools: a before and after study.

UK National Food Strategy: Tax sugar and salt and prescribe veg, report says.

Perspective – Sugar-sweetened beverage taxes: Lessons to date and the future of taxation

Cohort Study: Association Between Tax on Sugar Sweetened Beverages and Soft Drink Consumption

Meta-Analysis: Impact of Sugar‐sweetened Beverage Taxes on Purchases and Dietary Intake

Cochrane Review: Environmental Interventions to Reduce the Consumption of Sugar‐sweetened Beverages and Their Effects on Health

Study: Snack Tax May be More Effective than a Sugary Drink Tax to Tackle Obesity

Sugar Tax: Why Health Experts Want it But Politicians and Industry are Resisting

The Effect of Food Price Changes on Consumer Purchases: A Randomized Experiment

Taxes on Sugar-Sweetened Beverages Associated with Reduced Consumption

Soda Tax Linked to a 50 Percent Reduction in Sugary Drink Consumption

AAP/AHA Policy Statement: Public Policies to Reduce Sugary Drink Consumption in Children and Adolescents

Fiscal policies for diet and the prevention of noncommunicable diseases – World Health Organization

The Lancet taskforce on NCDs and economics

To improve global health, tax the things that are killing us – Financial Times

Reducing cardiovascular disease burden through targeted dietary policies

Fiscal policies for the prevention of diseases

The potential impact of food taxes and subsidies on cardiovascular disease and diabetes burden and disparities

RCT | Comparison of 3 Paclitaxel-based chemoradiotherapy regimens for patients with locally advanced esophageal squamous cell cancer.

22 Feb, 2022 | 08:19h | UTC

Comparison of 3 Paclitaxel-Based Chemoradiotherapy Regimens for Patients With Locally Advanced Esophageal Squamous Cell Cancer: A Randomized Clinical Trial – JAMA Network Open

RCT: Time to functional recovery after laser tonsillotomy performed under local anesthesia vs. conventional tonsillectomy with general anesthesia among adults.

22 Feb, 2022 | 08:22h | UTC

Time to Functional Recovery After Laser Tonsillotomy Performed Under Local Anesthesia vs Conventional Tonsillectomy With General Anesthesia Among Adults: A Randomized Clinical Trial – JAMA Network Open

Commentary on Twitter

RCT found laser tonsillotomy under local anesthesia had faster functional recovery but lower resolution of the chief complaint leading to surgery vs conventional tonsillectomy under general anesthesia; it may offer a feasible alternative. https://t.co/yfaWeFJeEl pic.twitter.com/DDYxlEhZEp

— JAMA Network Open (@JAMANetworkOpen) February 21, 2022

Monoclonal antibodies against rabies: current uses in prophylaxis and in therapy.

22 Feb, 2022 | 08:15h | UTC

Monoclonal antibodies against rabies: current uses in prophylaxis and in therapy – Current Opinion in Virology

Expert Analysis | Asymptomatic ventricular preexcitation (Wolff-Parkinson-White Pattern): when to be concerned.

22 Feb, 2022 | 08:18h | UTC

Asymptomatic Ventricular Preexcitation (Wolff-Parkinson-White Pattern): When to Be Concerned – American College of Cardiology

Personal View | Effective, disease-modifying, clinical approaches to patients with mild-to-moderate hypertriglyceridemia.

22 Feb, 2022 | 08:17h | UTC

Effective, disease-modifying, clinical approaches to patients with mild-to-moderate hypertriglyceridaemia – The Lancet Diabetes & Endocrinology (free for a limited period)

Dietary carbohydrate and the risk of type 2 diabetes: an updated systematic review and dose–response meta-analysis of prospective cohort studies.

22 Feb, 2022 | 08:16h | UTC

Dietary carbohydrate and the risk of type 2 diabetes: an updated systematic review and dose–response meta-analysis of prospective cohort studies – Scientific Reports

ESCMID rapid guidelines for assessment and management of long COVID.

21 Feb, 2022 | 09:31h | UTC

ESCMID rapid guidelines for assessment and management of long COVID – Clinical Microbiology and Infection

ERS statement on Long COVID-19 follow-up.

Proposed subtypes of long-Covid and their respective potential therapies.

EuGMS Guidance: Management of post-acute COVID-19 patients in geriatric rehabilitation.

Addressing Post-COVID Symptoms: A Guide for Primary Care Physicians.

Global surveillance, research, and collaboration needed to improve understanding and management of long COVID.

Provocative study suggests that persistent physical symptoms after COVID-19 infection may be associated more with the belief in having been infected with SARS-CoV-2 than with having laboratory-confirmed COVID-19 infection.

Update to post-acute sequelae of SARS-CoV-2 infection: Caring for the ‘long-haulers’.

Systematic Review: Short-term and long-term rates of postacute sequelae of SARS-CoV-2 infection.

WHO Consensus: A clinical case definition of post COVID-19 condition (Long Covid).

Characterizing long COVID: a living systematic review.

Long Covid – The illness narratives.

New guidelines to help doctors manage long COVID patients published.

M-A: More than 50 long-term effects of COVID-19. (several articles on the subject)

RCT: In patients with mild to moderate Covid-19 and comorbidities, treatment with Ivermectin did not reduce the risk of disease progression.

21 Feb, 2022 | 09:34h | UTC

Efficacy of Ivermectin Treatment on Disease Progression Among Adults With Mild to Moderate COVID-19 and Comorbidities: The I-TECH Randomized Clinical Trial – JAMA Internal Medicine

Commentaries:

Ivermectin doesn’t prevent severe disease from Covid-19, new study finds – CNN

Ivermectin futile for mild to moderate COVID-19, study finds – CIDRAP

Case Series: Toxic effects from ivermectin use associated with prevention and treatment of Covid-19.

Long-term consequences of the misuse of ivermectin data.

Ivermectin: How false science created a Covid ‘miracle’ drug.

Fraudulent ivermectin studies open up new battleground between science and misinformation.

The lesson of ivermectin: meta-analyses based on summary data alone are inherently unreliable.

Ivermectin: Cochrane’s most talked about review so far, ever. Why?

Flawed ivermectin preprint highlights challenges of COVID drug studies.

Systematic review: no evidence to support the use of Ivermectin for treating or preventing COVID-19.

Why was a major study on ivermectin for covid-19 just retracted?

RCT: Ivermectin does not prevent hospitalizations in patients with COVID-19.

Ivermectin for the treatment of COVID-19: A systematic review and meta-analysis of randomized controlled trials – “IVM did not reduce all-cause mortality, length of stay or viral clearance in RCTs in COVID-19 patients with mostly mild disease”.

Ivermectin is the new hydroxychloroquine, take 2 – “Ivermectin shouldn’t be used to treat COVID-19 outside of the context of a well-designed clinical trial”.

Therapeutics and COVID-19 | WHO guideline update advises Ivermectin should only be used to treat COVID-19 within clinical trials

RCT: Ivermectin does not improve time to resolution of symptoms among adults with mild COVID-19

RCT: Advising overweight patients to increase sleep duration may reduce caloric intake.

21 Feb, 2022 | 09:27h | UTC

Effect of Sleep Extension on Objectively Assessed Energy Intake Among Adults With Overweight in Real-life Settings: A Randomized Clinical Trial – JAMA Internal Medicine

News Release: Getting more sleep reduces caloric intake, a game changer for weight loss programs – University of Chicago Medical Center

Commentaries:

Cut nearly 300 calories a day by doing something you already do – CNN

Individualized Sleep Counseling Can Aid Weight Loss in Overweight – HealthDay

Commentary on Twitter

In this randomized clinical trial of overweight adults who habitually sleep <6.5 hours per night, sleep extension reduced daily energy intake by ~270 kcal. Maintaining adequate sleep duration could be a viable intervention to prevent or reverse obesity. https://t.co/4nURTFSMO0 pic.twitter.com/jXaRx7wOdG

— JAMA Internal Medicine (@JAMAInternalMed) February 7, 2022